LH
55
2
SYY
50
-8
TAP
51
-2
ADP
70
-3
AEE
61
-2
HUM
30
3
LYB
44
-2
CTAS
56
-5
CME
56
-3
EBAY
50
-3
O
35
-2
PAYX
53
-4
CI
66
-2
RIG
35
-3
VRTX
56
-4
AVY
54
-14
MA
65
-4
FLS
46
-7
CA
36
-4
SBUX
41
-3
LH
55
2
SYY
50
-8
TAP
51
-2
ADP
70
-3
AEE
61
-2
HUM
30
3
LYB
44
-2
CTAS
56
-5
CME
56
-3
EBAY
50
-3
O
35
-2
PAYX
53
-4
CI
66
-2
RIG
35
-3
VRTX
56
-4
AVY
54
-14
MA
65
-4
FLS
46
-7
CA
36
-4
SBUX
41
-3
Financhill
Back

Eli Lilly and 10K Form

Sell
47

LLY
Eli Lilly and

Last Price:
915.51
Seasonality Move:
4.48%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive LLY News And Ratings

See the #1 stock for the next 7 days that we like better than LLY

LLY Financial Statistics

Sales & Book Value

Annual Sales: $34.12B
Cash Flow: $63.4M
Price / Cash Flow: 0
Annual Sales: $15.06
Price / Book: 60.08

Profitability

EPS (TTM): 8.12000
Net Income (TTM): $7.34B
Gross Margin: $27.04B
Return on Equity: 61.34%
Return on Assets: 11.75%

Eli Lilly and Earnings Forecast

Key Eli Lilly and Financial Ratios

  • The Gross Profit Margin over the past 40 years for LLY is 79.25%.
  • The Selling, General & Administrative Expenses for LLY have been equal to 20.34% of Gross Profit Margin.
  • The Research & Development expenses have been 27.29% of Revenue.
  • The Interest Expense is 9.27% of Operating Income.
  • The Net Earning history of LLY is 15.36% of Total Revenues.
  • Per Share Earnings over the last 40 years have been positive in 23 years.

Eli Lilly and Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: S&P500
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: LLY
CUSIP: 532457
Website: lilly.com

Debt

Debt-to-Equity Ratio: 2.13
Current Ratio: 1.11
Quick Ratio: 0.61

Price-to-Earnings

Trailing P/E Ratio: 156.03
Forward P/E Ratio: 40.1

LLY Technical Analysis vs Fundamental Analysis

Sell
47
Eli Lilly and (LLY) is a Sell

Is Eli Lilly and a Buy or a Sell?

  • Eli Lilly and stock is rated a Sell
    The current Eli Lilly and [LLY] share price is $904.97. The Score for LLY is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.